PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
AboutPricing
Company Reports2seventy Bio
2seventy Bio(TSVT)
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
*Currency in USD
Loading
Company Revenue
Quarterly
Quarterly
Annual
Annual
Projections
*Quarterly sales USD (in millions)
Plot placeholder
Mock data
Subscribe for the real data
Revenue by Drug
Loading
Marketed Drugs
No data
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name
Phase 1
Phase 2
Phase 3
Phase 4
Indication
Lornoxicam
endometrial neoplasms
,
uterine cervical neoplasms
,
neuroblastoma
,
myeloid leukemia acute
,
neoplasms
,
precursor cell lymphoblastic leukemia-lymphoma
,
mantle-cell lymphoma
,
ovarian neoplasms
,
aids-related lymphoma
,
central nervous system neoplasms
,
sarcoma
,
rheumatoid arthritis
,
arthritis
,
recurrence
,
hiv infections
,
stem cell transplantation
,
systemic scleroderma
,
lung diseases
,
interstitial lung diseases
,
localized scleroderma
,
diffuse scleroderma
,
behcet syndrome
,
neoplasm metastasis
,
residual neoplasm
,
reactive arthritis
,
immunoblastic lymphadenopathy
,
glioma
,
large b-cell lymphoma diffuse
,
b-cell lymphoma
,
non-hodgkin lymphoma
,
triple negative breast neoplasms
,
inflammatory breast neoplasms
,
lupus nephritis
,
nephritis
,
colorectal neoplasms
,
mucinous adenocarcinoma
,
ductal carcinoma breast
,
patient preference
,
membranous glomerulonephritis
,
systemic lupus erythematosus
,
breast neoplasms
,
lymphoma
,
leukemia
,
b-cell chronic lymphocytic leukemia
,
lymphoid leukemia
,
follicular lymphoma
,
osteoporosis
,
postmenopausal osteoporosis
Cc5013
pancreatic ductal carcinoma
,
pancreatic neoplasms
,
adenocarcinoma
,
residual neoplasm
,
mantle-cell lymphoma
,
non-hodgkin lymphoma
,
b-cell lymphoma marginal zone
,
follicular lymphoma
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use